• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Oculeve

Allergan asks FDA to approve Oculeve neurostim device

July 18, 2016 By Brad Perriello

Allergan (NYSE:AGN) said today that it filed a de novo approval application with the FDA for its Oculeve nasal neurostimulation device for dry eye it bought last year. Oculeve is a hand-held device designed to be inserted into the nostril to stimulate the nerves serving the lacrimal gland. Allergan paid $125 million plus unspecified milestones for Oculeve last […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Optical/Ophthalmic, Regulatory/Compliance Tagged With: Allergan, Oculeve

Allergan’s Oculeve on track for FDA submission this year

May 16, 2016 By Brad Perriello

Allergan (NYSE:AGN) said today that it’s on track for an FDA submission this year for the Oculeve nasal neurostimulation device for dry eye it bought last year. Oculeve is a hand-held device designed to be inserted into the nostril to stimulate the nerves serving the lacrimal gland. Allergan paid $125 million plus unspecified milestones for Oculeve last year. Today the […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: Allergan, Oculeve

Allergan closes $125m Oculeve buy

August 11, 2015 By Fink Densford

Allergan said yesterday it closed its purchase of dry eye disease device developer Oculeve for $125 million in up-front payments in addition to unspecified commercialization milestones. South San Francisco-based Oculeve is developing a product called OD-01, a non-invasive nasal neurostimulation device designed to increase tear production in patients with dry eye disease, Allergan said. Oculeve has completed […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Allergan, Oculeve

Allergan to drop $125m on Oculeve

July 6, 2015 By Brad Perriello

Allergan (NYSE:AGN) said today that it agreed to pay $125 million up front to acquire Oculeve and its dry eye disease device program, plus unspecified commercialization milestones. South San Francisco-based Oculeve is developing a product called OD-01, a non-invasive nasal neurostimulation device designed to increase tear production in patients with dry eye disease, Allergan said. A pair […]

Filed Under: Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Allergan, Oculeve

Google Glass startup gains funding for flagship product | Medtech funding stories for the week of Mar. 17, 2014

March 21, 2014 By MassDevice staff Leave a Comment

Augmedix raises $3.2M for Google Glass for docs

March 19, 2014 by Arezu Sarvestani

Augmedix raises $3.2M for Google Glass for docs

Filed Under: Funding Roundup, News Well Tagged With: Alphabet (Google), Altitude Technologies, Augmedix, Bi02 Medical, defensedepartment, Draeger Medical, Oculeve, OnTarget Laboratories, Targeted Technology Fund, Texas Emerging Technology Fund, Zimmer Biomet

Oculeve raises $16.6M in support of dry eye disease treatment

March 19, 2014 By Arezu Sarvestani Leave a Comment

Oculeve raises $16.6M in support of dry eye disease treatment

San Francisco startup Oculeve Inc. closed a $16.6 million funding round in supports of its implantable technology for treatment of dry eye disease.

Filed Under: Funding Roundup, Neuromodulation/Neurostimulation, News Well, Optical/Ophthalmic Tagged With: Oculeve

Bidding war for Carestream heats up | Wall Street Beat

March 29, 2013 By Brad Perriello Leave a Comment

MassDevice.com Wall Street Beat

At least 5 major private equity players are vying for medical device company Carestream Health, including Bain Capital, Carlyle Group and KKR & Co., according to Reuters.

Onex Corp. is hoping to unload Carestream, formed in the 2007 spinout of Eastman Kodak Co.’s healthcare business, for up to $3.5 billion, the news service reported.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well Tagged With: Angiotech, Bain Capital, Carestream Health Inc., Carlyle Group, Hologic, Immucor Inc., Lumenis Ltd., Oculeve, Venture Capital/Private Equity

Cleveland HeartLab pulls in $15M | Wall Street Beat

November 1, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.

The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.

Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: 480 Biomedical, Arsenal Medical, Carestream Health Inc., Cleveland HeartLab LLC, conformis, Genesis Digital Imaging, LeMaitre Vascular Inc., neovasc, Oculeve

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy